- Home
- BLRX vs AQMS Comparison
BLRX vs AQMS Comparison
Compare BLRX & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLRX | AQMS |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 10.0M |
| IPO Year | 2010 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BLRX | AQMS |
|---|---|---|
| Price | $2.50 | $2.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $19.00 | $12.00 |
| AVG Volume (30 Days) | 18.6K | ★ 28.0K |
| Earning Date | 05-26-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,100,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $600.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $2.16 |
| 52 Week High | $4.56 | $39.37 |
Technical Indicators
Market Signals| Indicator | BLRX | AQMS |
|---|---|---|
| Relative Strength Index (RSI) | 40.14 | 38.63 |
| Support Level | $2.18 | $2.16 |
| Resistance Level | $2.51 | $2.98 |
| Average True Range (ATR) | 0.16 | 0.20 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 2.12 | 21.58 |
Price Performance
Historical ComparisonAbout BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is developing and seeking to commercialize proprietary recycling and refining technologies for the recovery of critical minerals and metals. Its patented and patent-pending AquaRefining process is an electro-hydrometallurgical method designed to recover high-purity materials from battery and other metal-bearing feedstocks using a closed-loop system powered by electricity. Its idea is to reduce CAPEX and OPEX costs, reduce emissions, hazardous waste, and reliance on conventional smelting and chemical-intensive refining processes. It has one operating segment: sustainable metals recycling. It focused on the development and commercialization of AquaRefining technology for the clean and efficient recovery of valuable metals from lead-acid and lithium-ion batteries.